Low-cost assays Salus Discovery focuses on lowering costs and improving performance through micro-scale assay development, presenting a clear value proposition for cost-conscious biotechs and contract research organizations seeking efficient screening and optimization solutions.

ESP technology The core Exclusion-Based Sample Preparation platform and EXTRACTMAN product offer scalable, easy-to-use tools, suggesting sales opportunities around automation-friendly sample prep for labs looking to streamline workflows and reduce hands-on time.

Academic roots Founded from university research with no external investors, Salus values collaborative partnerships across disciplines, signaling potential for teaming arrangements, co-development deals, and grant-aligned projects with research institutions and pharma partners.

BSL2 capabilities In-house fabrications, prototyping, and a BSL-2 lab enable safe work with cell culture and molecular biology, opening doors for early-access trials, pilot studies, and direct lab-to-market demonstrations for life science clients.

Healthcare focus Philanthropic orientation toward improving healthcare for underserved populations positions Salus as a partner for mission-driven programs, while also aligning with funder-backed collaborations and CSR-aligned client opportunities in biomedicine.